KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 109 filers reported holding KALA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 3.37 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2 | -97.3% | 10,741 | -95.6% | 0.00% | – |
Q2 2022 | $74 | -99.9% | 243,918 | +173.6% | 0.00% | – |
Q1 2022 | $123,000 | -50.0% | 89,162 | -56.2% | 0.00% | – |
Q4 2021 | $246,000 | -39.4% | 203,514 | +31.3% | 0.00% | – |
Q3 2021 | $406,000 | -52.3% | 154,957 | -3.6% | 0.00% | – |
Q2 2021 | $852,000 | +43.2% | 160,759 | +82.0% | 0.00% | – |
Q1 2021 | $595,000 | +87.1% | 88,337 | +88.0% | 0.00% | – |
Q4 2020 | $318,000 | -77.5% | 46,981 | -75.0% | 0.00% | – |
Q3 2020 | $1,412,000 | -57.7% | 188,298 | -40.7% | 0.00% | -100.0% |
Q2 2020 | $3,338,000 | -12.5% | 317,564 | -26.9% | 0.00% | 0.0% |
Q1 2020 | $3,817,000 | +1439.1% | 434,209 | +544.4% | 0.00% | – |
Q4 2019 | $248,000 | -35.6% | 67,387 | -33.4% | 0.00% | – |
Q3 2019 | $385,000 | +120.0% | 101,190 | +268.3% | 0.00% | – |
Q2 2019 | $175,000 | -59.1% | 27,473 | -46.9% | 0.00% | – |
Q1 2019 | $428,000 | +23.3% | 51,767 | -27.1% | 0.00% | – |
Q4 2018 | $347,000 | -42.5% | 71,045 | +16.2% | 0.00% | – |
Q3 2018 | $603,000 | +34.3% | 61,121 | +86.8% | 0.00% | – |
Q2 2018 | $449,000 | +34.4% | 32,727 | +54.9% | 0.00% | – |
Q1 2018 | $334,000 | +42.1% | 21,128 | +66.5% | 0.00% | – |
Q4 2017 | $235,000 | – | 12,691 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parallel Advisors, LLC | 1 | $7 | 0.00% |